thanks 4S for your reply
Keeping in mind Prochymal has already been granted both Orphan Drug and Fast Track status by the FDA. maybe MSB can go for Breakthrough Therapy Status too.
DYOR
Prochymal, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.055(5.16%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | $1.00 | $1.607M | 1.574M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 103300 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 9026 | 5 |
View Market Depth
| Last trade - 11.40am 04/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |